Healthcare Global Enterprises Ltd announced that its shareholders have approved the HCG Employee Stock Option Scheme 2026 and related resolutions through a remote e-voting process. The postal ballot, which concluded on July 08, 2026, sought approval for five special resolutions, including the grant of stock options to group company employees and the reappointment of key leadership personnel.

The scrutinizer's report, issued by Mr. V Sreedharan of V Sreedharan and Associates, confirmed that all five resolutions were passed with the requisite majority. The total number of valid votes polled across the resolutions was approximately 83.54% of the total paid-up equity capital. The resolutions included the approval of the ESOS 2026, the grant of options exceeding 1% of the issued share capital to a specific employee, and the reappointment of Mr. Rajiv Maliwal as an Independent Director.

Voting Results Summary

The following table details the voting outcomes for the key resolutions passed during the postal ballot:

Key Approvals

The reappointment of Mr. Rajiv Maliwal (DIN: 00869035) as an Independent Director received strong support, with 92.34% of the valid votes cast in favour. Additionally, shareholders approved the revision in remuneration for Dr. Manish Mattoo (DIN: 08431924), Executive Director and Chief Executive Officer of the Company. The voting was conducted exclusively through electronic means, with no physical postal ballots received.

HealthCare Global Enterprises Limited has completed the divestment of its entire equity shareholding in BACC Health Care Private Limited. The company transferred 93,577 shares, constituting approximately 99.999% of BACC, to Inviga Healthcare Fund I and its nominee on June 29, 2026. The transaction was executed pursuant to a Share Purchase Agreement dated May 19, 2026, approved by the board on the same day.

The total consideration for the sale is ₹37,64,44,788. Of this, the initial consideration of ₹28,23,33,591 was received on June 29, 2026. The remaining balance is a deferred consideration payable within 18 months from the date of signing the agreement, which is not conditional or contingent.

The transfer of one share held by a nominee on behalf of the company is currently under process. The divestment was intimated to the stock exchanges in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Transaction Details

The board approval for the sale was granted on May 19, 2026. The deferred payment is strictly time-based and carries no additional conditions.